Last 12 months
Inside the activity.
0 purchase rows · 26 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2021 Filed Mar 17, 2021 23:08 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 669 | $0.00 Strike: $59.32 | $0.00 |
DisclosureSEC source: 0001754499-21-000004 · edgardoc.xml · derivative · entry 6 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,174 Underlying: Common Stock · 669 shares Expires 2023-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option will vest based on achievement of certain performance criteria relating to earnings growth. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 23:08 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 331 | $0.00 Strike: $57.35 | $0.00 |
DisclosureSEC source: 0001754499-21-000004 · edgardoc.xml · derivative · entry 5 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354 Underlying: Common Stock · 331 shares Expires 2023-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 23:08 UTC |
O'Brien BrandonChief Financial Officer
|
SaleCommon Stock | 669 | $109.28 | $73,107.38 |
DisclosureSEC source: 0001754499-21-000004 · edgardoc.xml · nonDerivative · entry 4 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,568 Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 23:08 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionCommon Stock | 669 | $59.32 | $39,685.08 |
DisclosureSEC source: 0001754499-21-000004 · edgardoc.xml · nonDerivative · entry 3 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 23:08 UTC |
O'Brien BrandonChief Financial Officer
|
SaleCommon Stock | 331 | $109.28 | $36,171.22 |
DisclosureSEC source: 0001754499-21-000004 · edgardoc.xml · nonDerivative · entry 2 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,568 Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 23:08 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionCommon Stock | 331 | $57.35 | $18,982.85 |
DisclosureSEC source: 0001754499-21-000004 · edgardoc.xml · nonDerivative · entry 1 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,899 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 22:02 UTC |
CORSTAR HOLDINGS INC10% owner
|
SaleCommon Stock | 5,219 | $108.78 | $567,743.17 |
DisclosureSEC source: 0001256520-21-000010 · edgardoc.xml · nonDerivative · entry 1 CORSTAR HOLDINGS INC · CIK 0001256520 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,552,515 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on February 10, 2021. Read SEC document |
| March 12, 2021 Filed Mar 12, 2021 23:08 UTC |
CORSTAR HOLDINGS INC10% owner
|
SaleCommon Stock | 6,714 | $108.04 | $725,378.55 |
DisclosureSEC source: 0001256520-21-000008 · edgardoc.xml · nonDerivative · entry 3 CORSTAR HOLDINGS INC · CIK 0001256520 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,557,734 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on February 10, 2021. Read SEC document |
| March 11, 2021 Filed Mar 13, 2021 00:06 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,000 | $105.57 | $105,572.80 |
DisclosureSEC source: 0000946724-21-000019 · edgardoc.xml · nonDerivative · entry 2 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 633,750 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 23:08 UTC |
CORSTAR HOLDINGS INC10% owner
|
SaleCommon Stock | 2,868 | $106.37 | $305,071.17 |
DisclosureSEC source: 0001256520-21-000008 · edgardoc.xml · nonDerivative · entry 2 CORSTAR HOLDINGS INC · CIK 0001256520 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564,448 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on February 10, 2021. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 23:45 UTC |
JESSUP R JUDDDirector
|
SaleCommon Stock | 4,793 | $105.97 | $507,914.21 |
DisclosureSEC source: 0001204612-21-000004 · edgardoc.xml · nonDerivative · entry 1 JESSUP R JUDD · CIK 0001204612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,045 Read SEC document |
| March 10, 2021 Filed Mar 13, 2021 00:06 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,000 | $105.50 | $105,499.00 |
DisclosureSEC source: 0000946724-21-000019 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 634,750 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:08 UTC |
CORSTAR HOLDINGS INC10% owner
|
SaleCommon Stock | 3,043 | $105.71 | $321,690.14 |
DisclosureSEC source: 0001256520-21-000008 · edgardoc.xml · nonDerivative · entry 1 CORSTAR HOLDINGS INC · CIK 0001256520 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,567,316 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on February 10, 2021. Read SEC document |
| March 09, 2021 Filed Mar 9, 2021 23:17 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 500 | $106.23 | $53,115.00 |
DisclosureSEC source: 0000946724-21-000016 · edgardoc.xml · nonDerivative · entry 2 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 635,750 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| March 09, 2021 Filed Mar 9, 2021 22:14 UTC |
CORSTAR HOLDINGS INC10% owner
|
SaleCommon Stock | 5,508 | $105.70 | $582,209.37 |
DisclosureSEC source: 0001256520-21-000006 · edgardoc.xml · nonDerivative · entry 3 CORSTAR HOLDINGS INC · CIK 0001256520 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,570,359 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on February 10, 2021. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:24 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,267 | $0.00 Strike: $57.75 | $0.00 |
DisclosureSEC source: 0001754499-21-000002 · edgardoc.xml · derivative · entry 15 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,267 shares Expires 2022-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option will vest based on achievement of certain performance criteria relating to earnings growth. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:24 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 315 | $0.00 Strike: $57.35 | $0.00 |
DisclosureSEC source: 0001754499-21-000002 · edgardoc.xml · derivative · entry 14 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 685 Underlying: Common Stock · 315 shares Expires 2023-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:24 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 283 | $0.00 Strike: $49.40 | $0.00 |
DisclosureSEC source: 0001754499-21-000002 · edgardoc.xml · derivative · entry 13 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117 Underlying: Common Stock · 283 shares Expires 2023-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:24 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 31 | $0.00 Strike: $48.35 | $0.00 |
DisclosureSEC source: 0001754499-21-000002 · edgardoc.xml · derivative · entry 12 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31 Underlying: Common Stock · 31 shares Expires 2022-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:24 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 104 | $0.00 Strike: $45.90 | $0.00 |
DisclosureSEC source: 0001754499-21-000002 · edgardoc.xml · derivative · entry 11 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42 Underlying: Common Stock · 104 shares Expires 2022-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:24 UTC |
O'Brien BrandonChief Financial Officer
|
SaleCommon Stock | 104 | $105.75 | $10,998.00 |
DisclosureSEC source: 0001754499-21-000002 · edgardoc.xml · nonDerivative · entry 10 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,568 Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:24 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionCommon Stock | 104 | $45.90 | $4,773.60 |
DisclosureSEC source: 0001754499-21-000002 · edgardoc.xml · nonDerivative · entry 9 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,672 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:24 UTC |
O'Brien BrandonChief Financial Officer
|
SaleCommon Stock | 31 | $105.75 | $3,278.25 |
DisclosureSEC source: 0001754499-21-000002 · edgardoc.xml · nonDerivative · entry 8 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,568 Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:24 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionCommon Stock | 31 | $48.35 | $1,498.85 |
DisclosureSEC source: 0001754499-21-000002 · edgardoc.xml · nonDerivative · entry 7 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:24 UTC |
O'Brien BrandonChief Financial Officer
|
SaleCommon Stock | 1,267 | $105.75 | $133,985.25 |
DisclosureSEC source: 0001754499-21-000002 · edgardoc.xml · nonDerivative · entry 6 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,568 Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:24 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionCommon Stock | 1,267 | $57.75 | $73,169.25 |
DisclosureSEC source: 0001754499-21-000002 · edgardoc.xml · nonDerivative · entry 5 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:24 UTC |
O'Brien BrandonChief Financial Officer
|
SaleCommon Stock | 283 | $105.75 | $29,927.25 |
DisclosureSEC source: 0001754499-21-000002 · edgardoc.xml · nonDerivative · entry 4 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,568 Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:24 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionCommon Stock | 283 | $49.40 | $13,980.20 |
DisclosureSEC source: 0001754499-21-000002 · edgardoc.xml · nonDerivative · entry 3 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:24 UTC |
O'Brien BrandonChief Financial Officer
|
SaleCommon Stock | 315 | $105.75 | $33,311.25 |
DisclosureSEC source: 0001754499-21-000002 · edgardoc.xml · nonDerivative · entry 2 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,568 Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:24 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionCommon Stock | 315 | $57.35 | $18,065.25 |
DisclosureSEC source: 0001754499-21-000002 · edgardoc.xml · nonDerivative · entry 1 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2021 Filed Mar 9, 2021 22:14 UTC |
CORSTAR HOLDINGS INC10% owner
|
SaleCommon Stock | 6,370 | $106.47 | $678,185.87 |
DisclosureSEC source: 0001256520-21-000006 · edgardoc.xml · nonDerivative · entry 2 CORSTAR HOLDINGS INC · CIK 0001256520 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,575,867 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on February 10, 2021. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 23:17 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,500 | $104.50 | $156,742.95 |
DisclosureSEC source: 0000946724-21-000016 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 636,250 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 22:14 UTC |
CORSTAR HOLDINGS INC10% owner
|
SaleCommon Stock | 7,062 | $104.45 | $737,591.30 |
DisclosureSEC source: 0001256520-21-000006 · edgardoc.xml · nonDerivative · entry 1 CORSTAR HOLDINGS INC · CIK 0001256520 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,582,237 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on February 10, 2021. Read SEC document |
| March 04, 2021 Filed Mar 4, 2021 23:15 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 500 | $102.97 | $51,482.65 |
DisclosureSEC source: 0000946724-21-000014 · edgardoc.xml · nonDerivative · entry 3 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 637,750 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| March 04, 2021 Filed Mar 4, 2021 22:28 UTC |
CORSTAR HOLDINGS INC10% owner
|
SaleCommon Stock | 4,359 | $103.54 | $451,316.48 |
DisclosureSEC source: 0001256520-21-000004 · edgardoc.xml · nonDerivative · entry 3 CORSTAR HOLDINGS INC · CIK 0001256520 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,589,299 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on February 10, 2021. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 23:15 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,000 | $103.29 | $103,285.00 |
DisclosureSEC source: 0000946724-21-000014 · edgardoc.xml · nonDerivative · entry 2 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 638,250 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 22:28 UTC |
CORSTAR HOLDINGS INC10% owner
|
SaleCommon Stock | 5,026 | $103.11 | $518,225.83 |
DisclosureSEC source: 0001256520-21-000004 · edgardoc.xml · nonDerivative · entry 2 CORSTAR HOLDINGS INC · CIK 0001256520 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,593,658 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on February 10, 2021. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 23:15 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,000 | $104.20 | $104,195.10 |
DisclosureSEC source: 0000946724-21-000014 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 639,250 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 22:28 UTC |
CORSTAR HOLDINGS INC10% owner
|
SaleCommon Stock | 4,819 | $103.41 | $498,314.48 |
DisclosureSEC source: 0001256520-21-000004 · edgardoc.xml · nonDerivative · entry 1 CORSTAR HOLDINGS INC · CIK 0001256520 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,598,684 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on February 10, 2021. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 00:49 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 800 | $102.68 | $82,147.28 |
DisclosureSEC source: 0000946724-21-000012 · edgardoc.xml · nonDerivative · entry 2 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 640,250 F2 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| March 01, 2021 Filed Mar 1, 2021 23:18 UTC |
CORSTAR HOLDINGS INC10% owner
|
SaleCommon Stock | 4,033 | $103.75 | $418,418.51 |
DisclosureSEC source: 0001256520-21-000002 · edgardoc.xml · nonDerivative · entry 3 CORSTAR HOLDINGS INC · CIK 0001256520 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,603,503 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on February 10, 2021. Read SEC document |
| February 26, 2021 Filed Mar 1, 2021 23:18 UTC |
CORSTAR HOLDINGS INC10% owner
|
SaleCommon Stock | 7,213 | $101.75 | $733,893.18 |
DisclosureSEC source: 0001256520-21-000002 · edgardoc.xml · nonDerivative · entry 2 CORSTAR HOLDINGS INC · CIK 0001256520 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,607,536 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on February 10, 2021. Read SEC document |
| February 25, 2021 Filed Mar 2, 2021 00:49 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000946724-21-000012 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 641,050 F1 · balance_after: The reported gift was made by the Marie Eve Clemons Living Trust to the Clemons Family Foundation. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 23:18 UTC |
CORSTAR HOLDINGS INC10% owner
|
SaleCommon Stock | 4,287 | $102.06 | $437,552.23 |
DisclosureSEC source: 0001256520-21-000002 · edgardoc.xml · nonDerivative · entry 1 CORSTAR HOLDINGS INC · CIK 0001256520 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,614,749 F1 · kind: Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on February 10, 2021. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 20:14 UTC |
Yoss JenniferVice President of Accounting
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 375 | $0.00 Strike: $57.35 | $0.00 |
DisclosureSEC source: 0001754632-21-000004 · edgardoc.xml · derivative · entry 9 Yoss Jennifer · CIK 0001754632 · Vice President of Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225 Underlying: Common Stock · 375 shares Expires 2023-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 20:14 UTC |
Yoss JenniferVice President of Accounting
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 206 | $0.00 Strike: $49.40 | $0.00 |
DisclosureSEC source: 0001754632-21-000004 · edgardoc.xml · derivative · entry 8 Yoss Jennifer · CIK 0001754632 · Vice President of Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94 Underlying: Common Stock · 206 shares Expires 2023-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 20:14 UTC |
Yoss JenniferVice President of Accounting
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 438 | $0.00 Strike: $48.35 | $0.00 |
DisclosureSEC source: 0001754632-21-000004 · edgardoc.xml · derivative · entry 7 Yoss Jennifer · CIK 0001754632 · Vice President of Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62 Underlying: Common Stock · 438 shares Expires 2022-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 20:14 UTC |
Yoss JenniferVice President of Accounting
|
SaleCommon Stock | 438 | $104.76 | $45,884.79 |
DisclosureSEC source: 0001754632-21-000004 · edgardoc.xml · nonDerivative · entry 6 Yoss Jennifer · CIK 0001754632 · Vice President of Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205 Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 20:14 UTC |
Yoss JenniferVice President of Accounting
|
Exercise / conversionCommon Stock | 438 | $48.35 | $21,177.30 |
DisclosureSEC source: 0001754632-21-000004 · edgardoc.xml · nonDerivative · entry 5 Yoss Jennifer · CIK 0001754632 · Vice President of Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 20:14 UTC |
Yoss JenniferVice President of Accounting
|
SaleCommon Stock | 206 | $104.76 | $21,580.52 |
DisclosureSEC source: 0001754632-21-000004 · edgardoc.xml · nonDerivative · entry 4 Yoss Jennifer · CIK 0001754632 · Vice President of Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.